GE Healthcare Announces Strategic Partnerships with Process Analysis and Automation and MatriCal
News Jan 17, 2008
These partnerships will enable GE Healthcare to further extend its offering with the most comprehensive range of cellular analysis and automation solutions for the IN Cell Analyzer platform.
As PAA is a specialist in the automation field, this partnership will allow GE Healthcare to provide customers with a range of automation solutions for the company’s IN Cell Analyzer and LEADseeker platforms.
Components are matched, installations are co-ordinated and customers no longer have to work with multiple vendors to build an automation platform for high content analysis (HCA) and high throughput screening (HTS).
With the strategic supplier agreement with MatriCal, GE Healthcare can now offer 96 and 384 well, flat glass bottom microwell plates at a competitive rate. The flat glass bottom MatriPlates™ have the benefit of providing, low auto-fluorescence, evenness of the plate surface, and optimum optical viewing surface for cell based assays. Combined with the advanced highly sensitive IN Cell Analyzer imaging platform, optimal imaging performance can be achieved.
“These partnerships and agreements allow GE Healthcare to deliver complete solutions to our customers that are able to meet their specific requirements, whether they need automated systems or key accessories for their high content analysis workflow. This will enable customers to undertake cellular analysis with the optimum image quality and the highest efficiency,” said Ger Brophy, General Manager of Advanced Systems at GE Healthcare Life Sciences.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
New Drug Compounds Help Prevent Hearing LossNews
Researchers from St. Jude Children's Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE